Seftec 125 mg/1.25 ml (Pediatric Drops)
15 ml bottle: ৳ 50.00
Medicine Details
Category | Details |
---|---|
Generic | Cephradine |
Company | Apc pharma ltd |
Also available as |
Indications
- Treatment of upper respiratory tract infections
- Treatment of lower respiratory tract infections
- Treatment of urinary tract infections
- Treatment of skin and soft tissue infections
- Susceptibility to specific Gram-positive bacteria
- Susceptibility to specific Gram-negative bacteria
Pharmacology
- Broad-spectrum bactericidal antibiotic
- Active against gram-positive and gram-negative microorganisms
- Inhibition of cross-linking process in bacteria cell wall
Dosage & Administration
- For oral administration - Adults:
- Dosage for urinary tract infections
- Dosage for respiratory tract infections
- Dosage for skin and soft tissue infections
- For oral administration - Children:
- Total daily dose based on body weight
- Specific dosage for otitis media
- Maximum daily dosage
- For injectable administration - Adults:
- Usual dose
- Prophylactic dose
- For injectable administration - Children: Dosage based on body weight
Interaction
- Potential risk of kidney damage with nephrotoxic drugs
- Enhanced renal toxicity with diuretics and probenecid
Contraindications
Hypersensitivity to cephalosporins
Side Effects
- Common:
- Gastrointestinal disturbances
- Hypersensitivity phenomena
- Occasional:
- Glossitis
- Heartburn
- Dizziness
- Nausea
- Vomiting
- Diarrhoea
- Abdominal pain
- Rare:
- Skin reactions
- Joint pains
- Oedema
- Blood disorders
- Immune system reactions
- Psychiatric disorders
- Nervous system disorders
- Hepatobiliary disorders
- Renal and urinary disorders
- Elevation of blood parameters
Pregnancy & Lactation
- No demonstrated teratogenicity in animal studies
- Excreted in breast milk
- Caution advised for lactating mothers
Precautions & Warnings
- Potential for superinfection with prolonged use
- Risk of cross-sensitivity with penicillins
- Possible positive result in Coombs’ testing
- Potential for false positive urine glucose result
- Dosage adjustment in renal impairment
- Contains lactose, caution for specific conditions
Use in Special Populations
- Renal Impairment: Recommended doses based on creatinine clearance
- Additional Information:
- Higher doses may be required for chronic or severe infections
- Duration of treatment post-symptom resolution
- Monitoring required for chronic urinary tract infections
- Transfer from intramuscular/intravenous to oral therapy
Overdose Effects
- Non-specific symptoms
- Supportive treatment
- Potential need for gastric lavage
Therapeutic Class
First generation Cephalosporins
Storage Conditions
- Fresh preparation of suspension
- Usage duration of reconstituted suspension
- Usage duration of injection solutions
- Potency retention under specific storage conditions
- Dispensing only on prescription of a registered physician
Related Brands
- Seftec 125 mg/5 ml (Powder for Suspension) - apc-pharma-ltd
- Seftec 500 mg (Capsule) - apc-pharma-ltd
- Sefro 125 mg/1.25 ml (Pediatric Drops) - navana-pharmaceuticals-ltd
- Sefro DS 250 mg/5 ml (Powder for Suspension) - navana-pharmaceuticals-ltd
- Sefro 125 mg/5 ml (Powder for Suspension) - navana-pharmaceuticals-ltd